Robert John Mentz

I am a cardiologist with a clinical and research interest in heart failure (going from Failure to Function), including advanced therapies such as cardiac transplantation and mechanical assist devices or “heart pumps."

I serve our group as Chief of the Heart Failure Section.

I became a heart failure cardiologist in order to help patients manage their chronic disease over many months and years. I consider myself strongly committed to compassionate patient care with a focus on quality of life and patient preference.

I am the Co-Editor in Chief of the Journal of Cardiac Failure - The official journal of the Heart Failure Society of America.

My research interests are focused on treating co-morbid diseases in heart failure patients and improving outcomes across the cardiovascular spectrum through clinical trials and outcomes research. Below, you will find my specific research interests:

•     Cardiometabolic disease
•     Co-morbidity characterization (diabetes, sleep apnea, renal failure) in heart failure
•     Phenotypic characterization and risk prognostication of patients with heart failure
•     Role of surrogate and nonfatal endpoints in clinical heart failure trials
•     Biomarkers in heart failure
•     Novel pharmacological and non-pharmacological approaches to heart failure
•     Improving site-based heart failure research

I am a leading clinical trialist in both traditional and pragmatic studies having served as a trial leader for HEART-FID, TRANSFORM-HF and PARAGLIDE-HF. 

I serve as a Co-PI for the FDA’s Research Triangle CERSI (Center of Excellence in Regulatory Science and Innovation).